OurInsightsTitle

Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

The 2023 EB Insights Study: the impact of epidermolysis bullosa on carer health-related quality of life. Poster PCR226. Presented at: ISPOR Europe 2025; 10-12 November 2025; Glasgow, UK.

Register to access the Tolley insights